This episode features Dr Sophie Rees ( University of Warwick, Coventry, UK ) and Dr Ann Hutchinson ( University of Hull, Hull, UK )
Cancer patients are at an increased risk of thrombosis. Current guidance for treatment is injected anticoagulants although there is some doubt as to the long-term acceptability of injections to patients. Many cancer patients are unaware of their increased risk of thrombosis or of the symptoms that should prompt seeking medical attention. Cancer patients find injected anticoagulants acceptable in the context of cancer, especially when given support to overcome initial anxieties. Patients find taking tablets easier, but would only choose tablets over injections if found to be as safe and effective as injected anticoagulants. Cancer patients must be informed of their increased risk of thrombosis and the symptoms for which they should seek help. Rivaroxaban tablets could be offered as a choice when there are sufficient robust data to support the risk–benefit balance.
Full paper available from: https://journals.sagepub.com/doi/10.1177/0269216318815377
If you would like to record a podcast about your published (or accepted) Palliative Medicine paper, please contact Dr Amara Nwosu: email@example.com